A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.
about
Validation of the effects of TGF-β1 on tumor recurrence and prognosis through tumor retrieval and cell mechanical propertiesHuman family with sequence similarity 60 member A (FAM60A) protein: a new subunit of the Sin3 deacetylase complexHomeostatic Signaling by Cell-Cell Junctions and Its Dysregulation during Cancer ProgressionOther targeted drugs in melanomaTracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancerTargeted immune therapy of ovarian cancerThe CD47-binding peptide of thrombospondin-1 induces defenestration of liver sinusoidal endothelial cellsA review of the past, present, and future directions of neoplasiaNeoplasia: Where We Have Been and Where We Are GoingTransforming growth factor β signaling overcomes dasatinib resistance in lung cancerDifferential Proteome Analysis Identifies TGF-β-Related Pro-Metastatic Proteins in a 4T1 Murine Breast Cancer ModelDrug development against metastasis-related genes and their pathways: A rationale for cancer therapyComplete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathwayYiqi Huayu Jiedu Decoction Inhibits the Invasion and Metastasis of Gastric Cancer Cells through TGF-β/Smad Pathway.Antimetastatic role of Smad4 signaling in colorectal cancerSelective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients.Use of a TGFbeta type I receptor inhibitor in mouse skin carcinogenesis reveals a dual role for TGFbeta signaling in tumor promotion and progression.Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation.Naringenin decreases invasiveness and metastasis by inhibiting TGF-β-induced epithelial to mesenchymal transition in pancreatic cancer cells.Targeting Nodal in malignant melanoma cells.TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, ChinaHeterotaxin: a TGF-β signaling inhibitor identified in a multi-phenotype profiling screen in Xenopus embryos.Spatio-temporal distribution of Smads and role of Smads/TGF-β/BMP-4 in the regulation of mouse bladder organogenesisHomeoprotein Six1 increases TGF-beta type I receptor and converts TGF-beta signaling from suppressive to supportive for tumor growth.LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.Smoking attenuates transforming growth factor-β-mediated tumor suppression function through downregulation of Smad3 in lung cancerMannose-binding lectin inhibits monocyte proliferation through transforming growth factor-β1 and p38 signaling pathways.Claudin-3 overexpression increases the malignant potential of colorectal cancer cells: roles of ERK1/2 and PI3K-Akt as modulators of EGFR signaling.TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells.Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft model.Immunity and immune suppression in human ovarian cancer.Tight junction protein 1 is regulated by transforming growth factor-β and contributes to cell motility in NSCLC cells.Paraquat induces epithelial-mesenchymal transition-like cellular response resulting in fibrogenesis and the prevention of apoptosis in human pulmonary epithelial cells.Elevated cysteine-rich 61 mediates aberrant collagen homeostasis in chronologically aged and photoaged human skinElucidating the mechanism of regulation of transforming growth factor β Type II receptor expression in human lung cancer cell linesDelayed stress fiber formation mediates pulmonary myofibroblast differentiation in response to TGF-β.Dynamic actin remodeling during epithelial-mesenchymal transition depends on increased moesin expression.Stimulation of hepatocarcinogenesis by neutrophils upon induction of oncogenic kras expression in transgenic zebrafish.Suppression of transforming growth factor beta signalling aborts caerulein induced pancreatitis and eliminates restricted stimulation at high caerulein concentrations.Reversal of transforming growth factor-β induced epithelial-to-mesenchymal transition and the ZEB proteins
P2860
Q21246016-37E3AF04-9476-4A90-A868-00EA9C48F08EQ24298824-E6EDC27B-42C3-4E55-B44B-3BB995902032Q26768428-83836FD9-D7C4-4375-8944-8E3F0A4CF9C3Q26775594-DCBF4A28-0B7D-4A4C-88C1-D86C89F35F1AQ26829478-D57F11E1-B17D-4E35-B7BE-C84CA4D633DFQ28082828-65C9DB34-E25C-4F2C-89BE-429A92E255EAQ28293417-D5D1873C-D789-48DF-870E-1A41869E1C29Q28389391-BDADB068-6D6C-4256-9D68-6CFA8AA5D545Q28395095-F7828BFE-3FA5-4A94-A98D-0FC4EBFC1D37Q28542671-AE65CA94-B1E8-4F21-AF60-578E692AD0DDQ28547327-EEFE3622-F9AB-466C-91A1-17D70861A434Q29010479-F85C8BDA-B281-4758-BBD2-4BC47C9C5571Q33520113-74D36344-C100-4942-8429-14BF7597ADE2Q33678879-C1F5B615-244F-4FB3-8B5C-78583A2EAD19Q33698993-C8C7328B-BDCF-4D26-B9DE-A05D21C55D5EQ33739307-2F10E8D0-92F9-487F-8962-C7446225860FQ34363852-F51DE25E-1AD1-4DFB-A203-D89CF2DA38D5Q34426034-4F161B37-12E6-4BF1-A062-776DDE90938CQ34540060-8254E3AF-FA06-498D-8F7B-FDBCB2244AF6Q34610503-A10EDBDD-483A-4C5E-A76E-9CA1059015A8Q34611269-7D657684-DAE5-4749-9A7E-86C77A43FA37Q34632162-D70950BB-5DB8-450D-9850-191DB6D801F9Q34688761-70EB794F-1FEC-493F-93EF-89A6623C4B56Q34768886-98D545AA-3251-485C-98F0-94593EFDB50CQ34935319-EB0B1D73-AAAF-4D14-9904-C64008DD857BQ34986974-D0DC9B7F-D2F4-4B59-9228-1DD0166B5882Q34988458-6D1F5E04-E42E-4AA7-90D4-1CCDD48EC39AQ34999421-FFCD543C-8358-47A3-B801-87D54EBAF20FQ35008198-D8597E35-8B9F-4FC6-B19B-64EE63753B43Q35033110-3D06A1B7-8735-46BE-87CC-BABF970F5896Q35138135-BF1BF87A-4B14-4BF6-9626-F591DB9084ACQ35156485-C2946691-4106-4851-A5DB-A8280CC8740DQ35208873-565C9636-DC8D-43DF-BBA8-C089FAE8FFDAQ35221977-2594F8F7-AEB6-4D9A-8037-C65B67E3241FQ35444302-7BC7C1AE-E486-4E07-91A8-3536B967E9AFQ35543607-5532FC8E-72A9-4209-B1D0-407EA99C462FQ35612241-FA4564B5-F892-480D-BE12-EAE04CD30858Q35868513-592190D3-053C-470F-8F43-E6999CD3B1C6Q35929591-78737EEC-5488-4367-937E-6EAB8F10EB83Q36012598-3AEF278E-BB52-486E-829A-2E01C538032D
P2860
A specific inhibitor of TGF-beta receptor kinase, SB-431542, as a potent antitumor agent for human cancers.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A specific inhibitor of TGF-be ...... tumor agent for human cancers.
@ast
A specific inhibitor of TGF-be ...... tumor agent for human cancers.
@en
A specific inhibitor of TGF-be ...... tumor agent for human cancers.
@nl
type
label
A specific inhibitor of TGF-be ...... tumor agent for human cancers.
@ast
A specific inhibitor of TGF-be ...... tumor agent for human cancers.
@en
A specific inhibitor of TGF-be ...... tumor agent for human cancers.
@nl
prefLabel
A specific inhibitor of TGF-be ...... tumor agent for human cancers.
@ast
A specific inhibitor of TGF-be ...... tumor agent for human cancers.
@en
A specific inhibitor of TGF-be ...... tumor agent for human cancers.
@nl
P2860
P356
P1433
P1476
A specific inhibitor of TGF-be ...... itumor agent for human cancers
@en
P2093
Pran K Datta
Sunil K Halder
P2860
P304
P356
10.1593/NEO.04640
P577
2005-05-01T00:00:00Z